Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Cells and Tissue01:30

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAP1-RHO small GTPase cross-talk mediates integrin-dependent and -independent platelet procoagulant response.

Haematologica·2026
Same author

Affiliation in mice induced by an auditory-conditioned stimulus.

bioRxiv : the preprint server for biology·2026
Same author

Regulated RIAM-Talin Engagement Controls Adhesion Stability and Mechanical Output.

bioRxiv : the preprint server for biology·2026
Same author

Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

A CD25-chemokine receptor complex initiates noncanonical IL-2 signaling.

The Journal of biological chemistry·2025
Same author

Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 16, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Talin1 and Rap1 are critical for osteoclast function.

Wei Zou1, Takashi Izawa, Tingting Zhu

  • 1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.

Molecular and Cellular Biology
|December 12, 2012
PubMed
Summary

Talin1 is crucial for osteoclast function, impacting bone resorption. Inhibiting talin1 in mature osteoclasts significantly protects against bone loss in osteoporosis and arthritis models.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Related Experiment Videos

Last Updated: May 16, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Area of Science:

  • Cell Biology
  • Bone Biology
  • Integrin Signaling

Background:

  • Osteoclasts are critical for bone remodeling.
  • Integrin activation and cytoskeleton organization are essential for osteoclast function.
  • Talin1 is a key protein in integrin-mediated adhesion and signaling.

Purpose of the Study:

  • To investigate the role of talin1 in osteoclast differentiation and function.
  • To determine the impact of talin1 deficiency on bone mass and pathological bone loss.

Main Methods:

  • Generated genetically modified mice with targeted deletion of talin1 in osteoclasts (CtsK-TLN1) and osteoclast precursors (LysM-TLN1).
  • Assessed osteoclast differentiation, adhesion, migration, and bone resorption in vitro and in vivo.
  • Examined the effects of talin1 and Rap1 inhibition on bone loss in ovariectomy-induced osteoporosis and inflammatory arthritis models.

Main Results:

  • Absence of talin1 impairs M-CSF-stimulated integrin activation and cytoskeleton organization in mature osteoclasts.
  • Talin1-deficient osteoclast precursors exhibit defects in substrate attachment and migration, arresting development.
  • CtsK-TLN1 mice showed a significant increase in bone mass, indicating impaired bone resorption.
  • Osteoclast-specific deletion of Rap1 also resulted in osteopetrosis, suggesting a related mechanism.
  • Talin1 deletion protected mice from ovariectomy-induced osteoporosis and inflammatory arthritis-associated osteolysis.

Conclusions:

  • Talin1 is essential for osteoclast resorptive function and proper integrin activation.
  • Rap1 plays a critical role in talin/integrin interactions and osteoclast function.
  • Selective inhibition of talin1 in mature osteoclasts offers a potential therapeutic strategy for pathological bone loss.